Skip to main
RVTY

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 14 analyst ratings
Hold
Strong Buy 14%
Buy 21%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Revvity is a global life sciences and diagnostics company with a unique portfolio that presents potential for margin expansion and growth in the Life Science Solutions segment despite industry challenges. However, future performance may be affected by competition and declining birth rates in the Reproductive Health business. The company's Signals platform and divestiture in the China ImmunoDx business are expected to drive growth, but there are concerns about meeting growth targets and potential risks. Overall, Revvity has a positive outlook with potential for growth but it may face challenges in meeting targets and navigating competition.

Bears say

Revvity is a global company with a diverse portfolio of products and services, but its sales are susceptible to currency and economic risks. Additionally, its reliance on funding from the highly volatile biopharmaceutical and academic sectors, combined with increasing competition and slower recovery in key markets, creates further challenges for sustained growth. The company's recent targeted acquisitions and divestitures may also pose risks by shifting its focus away from a potentially lucrative market, such as the rapidly aging and underpenetrated China autoimmune testing market. Overall, there may be limited self-help opportunities for the company, and its near-term prospects may not be as strong as initially projected, which could negatively affect its stock's performance.

Revvity Inc (RVTY) has been analyzed by 14 analysts, with a consensus rating of Hold. 14% of analysts recommend a Strong Buy, 21% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Hold based on their latest research and market trends.

According to 14 analysts, Revvity Inc (RVTY) has a Hold consensus rating as of Sep 17, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $116.43, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $116.43, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.